Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementiaZachary C. Rosenthal, Stephen J. Haggarty, Daniel M. Fass et al.|Scientific Reports|2024Cited by 11